Discovery of AZD9750, an Orally Bioavailable Androgen Receptor Degrader for the Treatment of Prostate Cancer

发表于 2026-7-30 11:20:36

期刊：Journal of Medicinal Chemistry

文献作者：James S. Scott; Laura Evans; Peter C. Astles; Argyrides Argyrou; Sharan K. Bagal; David Beattie; Erin L. Braybrooke; Doyle J. Cassar; Claire Crafter; Coura Diène; Gary Fairley; Charlene Fallan; Graham Fraser; Nuria Galeano-Dalmau; Thomas G. Hammond; Andreas K. Hock; Thomas Jones; Jasper Komen; Gillian M. Lamont; Chrysiis Michaloglou; Michael J. Niedbala; Antonio Ramos-Montoya; Monica C. Rodrigo-Brenni; Martin J. Packer; Stuart Pearson; Andy Pike; Markus Schade; Joseph Shaw; Ziyanda Shologu; Oliver Steward

出版日期：2026-2-12

DOI号：10.1021/acs.jmedchem.5c03138

下载链接：https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5c03138

文献链接：https://doi.org/10.1021/acs.jmedchem.5c03138

当前文献来源于 American Chemical Society (ACS)。

备注信息：

发表于 2026-7-30 11:20:37

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[ACS] Discovery of AZD9750, an Orally Bioavailable Androgen Receptor Degrader for the Treatment of Prostate Cancer

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[ACS] Discovery of AZD9750, an Orally Bioavailable Androgen Receptor Degrader for the Treatment of Prostate Cancer 一键复制